Related Experiment Video

Updated: Jun 4, 2026

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR (qPCR)
08:30

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR (qPCR)

Published on: May 16, 2012

PMEPA1 promotes androgen receptor-negative prostate cell proliferation through suppressing the Smad3/4-c-Myc-p21 Cip1

Rong Liu1, Zhongmei Zhou, Jian Huang

  • 1The Center for Cell Biology and Cancer Research, Albany Medical College, 47 New Scotland Avenue, Albany, NY 12208, USA.

The Journal of Pathology
|February 23, 2011
PubMed

Insights

The PMEPA1 gene promotes prostate cancer growth by suppressing p21 expression in AR-negative cells. Inhibiting PMEPA1 reduces tumor growth, suggesting it

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The PMEPA1 gene is implicated in prostate tumors and known to inhibit androgen receptor (AR) and TGFβ signaling.
  • Its specific role in AR-negative prostate cancer remains largely unknown.

Purpose of the Study:

  • To elucidate the function and mechanism of PMEPA1 in AR-negative prostate cancer.
  • To investigate PMEPA1's impact on cell proliferation and its interaction with key signaling pathways.

Main Methods:

  • Cell proliferation assays in RWPE1 and PC-3 cell lines with PMEPA1 inhibition or overexpression.
  • Western blotting to assess protein levels and phosphorylation (p21, c-Myc, Smad3).
  • Gene silencing techniques (siRNA) targeting Smad3/4 and xenograft studies in mice.

Main Results:

  • PMEPA1 inhibition suppressed prostate cancer cell proliferation by upregulating p21 transcription.
  • PMEPA1 overexpression decreased p21, increased c-Myc, and promoted cell proliferation.
  • PMEPA1's function is dependent on its Smad2/3 binding motif, with Smad3/4 depletion blocking its effects.
  • Depletion of PMEPA1 inhibited xenograft tumor growth in vivo.

Conclusions:

  • PMEPA1 promotes AR-negative prostate cancer cell proliferation, potentially through the downregulation of p21.
  • PMEPA1 acts as a negative feedback regulator in the TGFβ pathway, influencing Smad3 and c-Myc.
  • PMEPA1 is overexpressed in some prostate cancers and represents a potential therapeutic target.

More Related Videos

miRNA Expression Analyses in Prostate Cancer Clinical Tissues11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...